GLP dominates today’s research conversations, yet it’s often misunderstood as something entirely different. In nonclinical research, GLP stands for Good Laboratory Practice; a critical quality system framework that ensures studies and their data are reliable, reproducible, and acceptable to regulatory bodies worldwide.

But in everyday conversation, those same three letters are often confused with GLP-1, the class of metabolic hormones behind a new wave of weight-loss medications like semaglutide and tirzepatide.

GLP: The Backbone of High-Quality Nonclinical Research

Good Laboratory Practice (GLP) isn’t a buzzword or a trend. It is a regulatory expectation designed to protect the integrity of nonclinical safety studies.

A GLP-compliant study ensures:

· Accurate data collection

· Clear documentation of procedures and results

· Robust quality assurance oversight

· Reproducibility of every step, from Test Article receipt to sample handling to reporting

· Confidence that findings are controlled and reflect true science, not variability or bias

For sponsors preparing investigational new drug (IND) submissions, GLP is a non-negotiable foundation that supports the safety profile of new therapeutics.

Simply put: If it isn’t GLP, regulators cannot depend on the data.

At Attentive Science, we believe it’s important to bring the focus back to where it truly matters for drug developers, biotechnology innovators, and regulatory partners; GLP as the gold standard of nonclinical study execution.

GLP-1: A Completely Different World

GLP-1, on the other hand, refers to glucagon-like peptide-1, a hormone involved in insulin secretion and appetite regulation. This biology is the basis for popular metabolic and weight-loss therapies.

While GLP-1 medications have generated tremendous public interest, they have nothing to do with the quality systems that govern nonclinical studies.

Why the Difference Matters for Sponsors and Scientists

In research and development, a single acronym can carry very different meanings, and GLP is a perfect example.

For scientists, GLP refers to Good Laboratory Practice, the regulatory framework that governs how studies are planned, executed, and reported. For many outside the scientific community, however, the term can easily be confused with GLP-1, the now well-known class of medications used in metabolic and weight-management therapies.

When these terms are used interchangeably in conversations, even unintentionally, it can create misunderstandings about study design, quality expectations, and regulatory requirements.

Whether you are a researcher or a non-scientist engaging with scientific teams, it’s worth pausing to ensure that everyone is speaking the same language when the acronym “GLP” comes up. A little clarity goes a long way in keeping discussions productive, and in making sure that complex scientific topics remain accessible to all readers and stakeholders.

A final point worth highlighting especially for those newer to the regulatory landscape, is that GLP studies do not automatically mean larger studies, more test systems, or additional assays. GLP is fundamentally about quality assurance, not study size or scientific scope. The purpose of GLP is to ensure that whatever work is performed, whether small or extensive, is conducted with traceability, consistency, and regulatory rigor. This distinction is often misunderstood, even among some professionals involved in biotechnology who may not work directly with GLP-governed studies. By clarifying that GLP governs how a study is executed rather than how much science is required, we can help demystify the process and reduce unnecessary hesitation around GLP adoption.

Attentive Science: Keeping GLP at the Centre of Nonclinical Excellence

At Attentive Science, we specialize in delivering GLP-compliant nonclinical studies that bridge animal health and human health, and regulatory success. Our commitment to GLP ensures that every study, whether analytical pharmacokinetics, toxicology, or safety pharmacology is guided by scientific rigor, transparent processes, meticulous documentation and focus on data integrity and regulatory expectations.

Good Laboratory Practice isn’t a trend. It’s a commitment to quality, to accuracy, and to ensuring safer, healthier outcomes.

And at Attentive Science, that commitment remains at the heart of everything we do.